000			02071 a2200553 4500
005			20250516131543.0
264		0	_c20130705
008			201307s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0051805 _2doi
040			_aNLM _beng _cNLM
100	1		_aLamb, Lawrence S
245	0	0	_aEngineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy. _h[electronic resource]
260			_bPloS one _c2013
300			_ae51805 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents, Alkylating _xpharmacology
650	0	4	_aBrain Neoplasms _ximmunology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCytotoxicity, Immunologic _xdrug effects
650	0	4	_aDacarbazine _xanalogs & derivatives
650	0	4	_aDiphosphonates _xpharmacology
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aFlow Cytometry
650	0	4	_aGPI-Linked Proteins _ximmunology
650	0	4	_aGenetic Engineering
650	0	4	_aGenetic Vectors _xgenetics
650	0	4	_aGlioblastoma _ximmunology
650	0	4	_aHumans
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aIntercellular Signaling Peptides and Proteins _ximmunology
650	0	4	_aInterleukin-2 _xpharmacology
650	0	4	_aLentivirus _xgenetics
650	0	4	_aO(6)-Methylguanine-DNA Methyltransferase _xgenetics
650	0	4	_aReceptors, Antigen, T-Cell, gamma-delta _ximmunology
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aTemozolomide
650	0	4	_aZoledronic Acid
700	1		_aBowersock, Joscelyn
700	1		_aDasgupta, Anindya
700	1		_aGillespie, G Yancey
700	1		_aSu, Yun
700	1		_aJohnson, Austin
700	1		_aSpencer, H Trent
773	0		_tPloS one _gvol. 8 _gno. 1 _gp. e51805
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0051805 _zAvailable from publisher's website
999			_c22425672 _d22425672